alexa Citations Report - Journal of Addiction Research and Therapy | 34
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2384

Journal of Addiction Research & Therapy received 2384 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 23, which means every article in Journal of Addiction Research & Therapy has got 23 average citations.

Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.

  2020 2019 2018 2017 2016

Year wise published articles

0 0 9 59 48

Year wise citations received

377 318 331 277 262
Journal total citations count 2384
Journal impact factor 12.60
Journal 5 years impact factor 9.26
Journal cite score 10.77
Journal h-index 23
Journal h-index since 2016 20
image

Becker JB (2016) Sex differences in addiction. Dialogues in clinical neuroscience 18: 395.

  View at Publisher | View at Google Scholar
image

Becker JB, McClellan ML, Reed BG (2017) Sex differences, gender and addiction. Journal of neuroscience research 2: 136-147.

  View at Publisher | View at Google Scholar
image

Richard JE, Anderberg RH, López-Ferreras L, Olandersson K, Skibicka KP (2016) Sex and estrogens alter the action of glucagon-like peptide-1 on reward. Biology of sex differences 7: 6.

  View at Publisher | View at Google Scholar
image

Twining RC, Tuscher JJ, Doncheck EM, Frick KM, Mueller D (2013) 17β-Estradiol is necessary for extinction of cocaine seeking in female rats. Learning & memory 20: 300-306.

  View at Publisher | View at Google Scholar
image

Cruz G, Riquelme R, Espinosa P, Jara P, Dagnino-Subiabre A, Renard GM, Sotomayor-Zarate R (2014) Neonatal exposure to estradiol valerate increases dopamine content in nigrostriatal pathway during adulthood in the rat. Hormone and Metabolic Research 46: 322-327.

  View at Publisher | View at Google Scholar
image

Cox KH, Bonthuis PJ, Rissman EF (2014) Mouse model systems to study sex chromosome genes and behavior: relevance to humans. Frontiers in neuroendocrinology 35: 405-419.

  View at Publisher | View at Google Scholar
image

Perry AN, Westenbroek C, Becker JB (2013) The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PloS one 8: e79465.

  View at Publisher | View at Google Scholar
image

dos Reis AS, em Álcool UD. Revisão da Literatura Sobre a Associação entre Tabagismo e Esquizofrenia.

  View at Publisher | View at Google Scholar
image

Almadana Pacheco V. Niveles de ansiedad y depresión en los fumadores que acuden a una consulta de deshabituación tabáquica y factores relacionados.

  View at Publisher | View at Google Scholar
image

García-Portilla MP, Bobes J (2016) Programas de cesación tabáquica para personas con esquizofrenia: una necesidad urgente no cubierta. Revista de Psiquiatría y Salud Mental 9: 181-184.

  View at Publisher | View at Google Scholar
image

Roig Cutillas P, Pinet Ogué M, Ballbè Gibernau M, Nieva Rifá G, Mondon Vehils S, et al. Vareniclina en el tratamiento del tabaquismo: efi cacia y seguridad en población general, psiquiátrica y drogodependiente.

  View at Publisher | View at Google Scholar
image

Kurita M, García-Bea A, González-Maeso J (2016) Novel Targets for Drug Treatment in Psychiatry. InThe Medical Basis of Psychiatry. Springer New York.

  View at Publisher | View at Google Scholar
image

García-Portilla MP, Bobes J (2016) Smoking cessation programs for persons with schizophrenia: An urgent unmet need. Revista de psiquiatria y salud mental 9: 181.

  View at Publisher | View at Google Scholar
image

Deepika M. Research and Reviews: Journal of Medical and Health Sciences.

  View at Publisher | View at Google Scholar
image

Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, et al. (2016) It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophrenia research 176: 272-280.

  View at Publisher | View at Google Scholar
image

Hughes JR (2016) Varenicline as a cause of suicidal outcomes. Nicotine & Tobacco Research 18: 2-9.

  View at Publisher | View at Google Scholar
image

Roberts E, Eden Evins A, McNeill A, Robson D (2016) Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta‐analysis. Addiction.

  View at Publisher | View at Google Scholar
image

Kishi T, Iwata N (2015) Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. European archives of psychiatry and clinical neuroscience 265: 259-268.

  View at Publisher | View at Google Scholar
image

Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, et al. (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet 387: 2507-2520.

  View at Publisher | View at Google Scholar
image

Aubin HJ, Luquiens A, Berlin I (2014) Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. British journal of clinical pharmacology 77: 324-336.

  View at Publisher | View at Google Scholar
Peer Reviewed Journals

Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals

International Conferences 2021-22
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

 
© 2008- 2021 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
+441518081309